StockNews.AISignal intelligencePublic signal · 1-minute delayed
Source-backed market context you can read and share without an account.
Bullish: the target increase and positive quarter commentary support upside, with substantial uncertainty because the target is an analyst opinion.
What happened, with direct paths to the underlying reporting
Raymond James raised its PGEN price target to $12, citing a stellar quarter for PAPZIMEOS. The stated target is well above the posted price of $5.06, though an analyst target is an opinion, not a forecast guarantee.
Target: $12
Posted price: $5.06
Analyst firm: Raymond James
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.